Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 7,400 shares at $16.33 ($120K) on 2008-01-02, disclosed to the SEC on 2008-01-03.
Scheduled sale ($120k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.21 | 100 | $2K | 1.3% |
| 2 | $15.36 | 100 | $2K | 1.3% |
| 3 | $15.55 | 100 | $2K | 1.3% |
| 4 | $15.65 | 100 | $2K | 1.3% |
| 5 | $15.82 | 200 | $3K | 2.6% |
| 6 | $15.83 | 100 |
| $2K |
| 1.3% |
| 7 | $15.88 | 100 | $2K | 1.3% |
| 8 | $15.93 | 100 | $2K | 1.3% |
| 9 | $16.08 | 300 | $5K | 4.0% |
| 10 | $16.11 | 100 | $2K | 1.3% |
| 11 | $16.13 | 300 | $5K | 4.0% |
| 12 | $16.14 | 200 | $3K | 2.7% |
| 13 | $16.16 | 300 | $5K | 4.1% |
| 14 | $16.17 | 600 | $10K | 8.1% |
| 15 | $16.18 | 600 | $10K | 8.1% |
| 16 | $16.19 | 400 | $6K | 5.4% |
| 17 | $16.20 | 400 | $6K | 5.4% |
| 18 | $16.22 | 400 | $6K | 5.4% |
| 19 | $16.23 | 100 | $2K | 1.4% |
| 20 | $16.25 | 300 | $5K | 4.1% |
| 21 | $16.28 | 300 | $5K | 4.1% |
| 22 | $16.29 | 300 | $5K | 4.1% |
| 23 | $16.33 | 500 | $8K | 6.8% |
| 24 | $16.34 | 300 | $5K | 4.1% |
| 25 | $16.35 | 100 | $2K | 1.4% |
| 26 | $16.37 | 400 | $7K | 5.5% |
| 27 | $16.38 | 300 | $5K | 4.1% |
| 28 | $16.40 | 100 | $2K | 1.4% |
| 29 | $16.45 | 200 | $3K | 2.7% |
| Total | $16.17 avg | 7,400 | $120K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $42K | — | Filing → |